Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma.
| Publicado en: | Strahlentherapie und Onkologie Vol. 201; no. 10; pp. 979 - 992 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Oct2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188453208&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 188453208 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01797158 NZE jtl: Strahlentherapie und Onkologie issn: 01797158 maglogo: N pubinfo: dt: Oct2025 vid: 201 iid: 10 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 188453208 182181223 10.1007/s00066-024-02347-y 188453208 ppf: 979 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma. aug: au: Lv, Xiaoyan Wang, Shuai Zhang, Wencheng Pang, Qingsong Lin, Qiang Wu, Yajing Hui, Zhouguang Liu, Yueping Cheng, Yunjie Liu, Qing Wang, Jun affil: https://ror.org/01mdjbm03 Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Hebei Clinical Research Center for Radiation Oncology, 050011, Shijiazhuang, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|